
Lincbiotech is a startup dedicated to developing innovative diagnostic and treatment solutions for prevalent neurological diseases like stroke and Alzheimer's. They leverage advanced neuroimaging processing, in-vitro assays, and artificial intelligence to enable timely and accurate diagnoses. Their product suite includes Minerva, a clinical decision support system for stroke patients, and novel monoclonal antibodies and ELISA kits for Alzheimer's diagnosis and treatment. The company focuses on improving clinical management and patient prognosis for these debilitating conditions.

Lincbiotech is a startup dedicated to developing innovative diagnostic and treatment solutions for prevalent neurological diseases like stroke and Alzheimer's. They leverage advanced neuroimaging processing, in-vitro assays, and artificial intelligence to enable timely and accurate diagnoses. Their product suite includes Minerva, a clinical decision support system for stroke patients, and novel monoclonal antibodies and ELISA kits for Alzheimer's diagnosis and treatment. The company focuses on improving clinical management and patient prognosis for these debilitating conditions.